Nrf2 enhances angiogenesis under hypoxic conditions by stabilizing hypoxia-inducible factor 1 alpha (HIF-1α) and inducing VEGF expression, whereas inhibition of Nrf2 reduces tumor vascularization and growth in xenograft models [212]. The gene discussed is NFE2L2; the disease is neoplasm.